Crennen Lyndsey Elizabeth
CAO
Crennen Lyndsey Elizabeth has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.
On the most recent filing, Crennen Lyndsey Elizabeth is listed as CAO at MESA LABORATORIES INC. Inside the rolling window, Crennen Lyndsey Elizabeth reported no open-market purchases and 2 open-market sales totaling $52K in MLAB. The largest disclosed transaction in the window is a sale of 442 MLAB shares on Jun 22, 2026, worth $40K.
Companies traded
Other insiders at MLAB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$52K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Crennen Lyndsey Elizabeth made?
Crennen Lyndsey Elizabeth has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Crennen Lyndsey Elizabeth trade?
Crennen Lyndsey Elizabeth has filed SEC Form 4 disclosures for 1 company, including MLAB.
When was Crennen Lyndsey Elizabeth's most recent SEC Form 4 filing?
Crennen Lyndsey Elizabeth's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.
What is Crennen Lyndsey Elizabeth's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Crennen Lyndsey Elizabeth is listed as CAO.
What is Crennen Lyndsey Elizabeth's total buy and sell value in the current window?
Inside the rolling retention window, Crennen Lyndsey Elizabeth bought $0 and sold $52K based on SEC Form 4 filings.
What was Crennen Lyndsey Elizabeth's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 442 MLAB shares on 2026-06-22, worth $40K, per SEC Form 4 filings.